Tuesday, November 29, 2022
Home Tags Vaccines

Vaccines Related News

NHS offers second monkeypox vaccination for eligible people

NHS offers second monkeypox vaccination for eligible people

The NHS will now offer a second monkeypox vaccination to everyone who is eligible in an effort to provide long-term protection against the virus. Around...
40 million children are dangerously susceptible to the measles virus

40 million children are dangerously susceptible to the measles virus

New data from WHO and the CDC confirms that almost 40 million children worldwide are becoming dangerously susceptible to the measles virus. The measles virus...
Defence's successful study on the ACCUVAC-PT007 vaccine

Defence’s successful study on the ACCUVAC-PT007 vaccine

Defence Therapeutics Inc. has announced its successful study on its ACCUVAC-PT007 vaccine, which targets cervical cancer. Defence Therapeutics Inc. a Canadian biopharmaceutical company specialised in...
Increasing children’s vaccines with effective vaccine strategies

Increasing children’s vaccines with effective vaccine strategies

A new study has found that increasing children’s vaccines in sub-Saharan Africa could reduce the chance of fatal disease infection. A research team from the...
COVID-19

Towards the next Council conclusions: are we doing enough for adult immunisation?

Ahead of a meeting between EU health ministers on vaccination policy in November this year, Mariano Votta and Daniela Quaggia from the Active Citizenship...
WHO: First data released on the global vaccine market since COVID 

WHO: First data released on the global vaccine market since COVID 

The World Health Organization (WHO) has captured the effects of COVID-19 on global vaccine markets in a new report.   WHO’s Global Vaccine Market Report...
Obesity in young people is one of the key causes of arterial fibrillation

COVID-19 vaccination does not affect nasopharyngeal cancer treatment 

The COVID-19 vaccine has been proven not to reduce the efficacy of nasopharyngeal cancer treatment, despite previous concerns.   Drugs that activate the immune system against tumours...
Health Europa Quarterly Issue 23

Health Europa Quarterly Issue 23

Welcome to Health Europa Quarterly Issue 23, which features fascinating expert insights in the fields of infection control, future pandemic preparedness, antimicrobial resistance, women’s health,...
Defence Therapeutics applies Accum technology to cancer vaccines

Defence Therapeutics applies Accum technology to anti-cancer vaccine

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is initiating a new research and...

Over 10 million people receive their COVID-19 booster 

New data from NHS England has revealed that over 10 million people have received their COVID-19 booster.  The NHS has recently welcomed more people to...
Anxiety disorders had no effect on COVID-19 vaccine hesitancy

Anxiety disorders had no effect on COVID-19 vaccine hesitancy

A new study has found that individuals with anxiety disorders were no less hesitant to get the COVID-19 vaccine. Researchers from the University of Waterloo...
Ground-breaking Hepatitis C virus imaging could lead to vaccine

Ground-breaking Hepatitis C virus imaging could lead to vaccine 

A team of researchers from Scripps Research and the University of Amsterdam have learned how to map high-resolution images of critical proteins on the...
Two-dose cholera vaccine strategy suspended by ICG

Two-dose cholera vaccine strategy suspended by ICG 

The International Coordinating Group (ICG), which manages emergency vaccine supplies has temporarily suspended their standard two-dose cholera vaccine strategy in response to the global...
New malaria vaccination could be deployed by 2023

New malaria vaccination could be deployed by 2023

A new malaria vaccination, developed by the University of Oxford, could be launched in 2023 after trials find it to be 80% effective.  The new...
Defence Therapeutics launches new AccuTOX lung cancer treatment

Defence Therapeutics launches new AccuTOX lung cancer treatment

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the start...
Secop Group and B Medical Systems announce cold chain solutions partnership

Secop Group and B Medical Systems announce cold chain solution partnership

A new agreement between Secop Group and B Medical Systems will provide new cold chain solutions for the transportation of vaccines, biospecimens and temperature-sensitive...
The teenage meningitis vaccine delivers herd immunity to all ages

The teenage meningitis vaccine delivers herd immunity to all ages

Researchers from the University of Oxford have found that the UK’s MenACWY meningitis vaccine programme generates herd protection protecting all age groups. In the new...
New tool prioritises countries in need of COVID-19 vaccines

New tool prioritises countries in need of COVID-19 vaccines

A new scoring tool developed by the University College London (UCL) assesses which countries require COVID-19 vaccines most. Throughout the COVID-19 pandemic, vaccine inequalities were...
NHS urge parents to book MMR vaccination for children

NHS urge parents to book MMR vaccination for children

The NHS is campaigning for parents and carers to book their children for the MMR vaccination by sending reminders through text, email and letters. In...
Defence Therapeutics have been granted patents for their anti drug conjugate technology

Accum A1-reprogrammed vaccine cured 80% of animals with pre-established lymphoma

Defence Therapeutics Inc, a Canadian biopharmaceutical company specialising in developing immune-oncology vaccines and drug delivery technologies, are pleased to report that Defence’s novel vaccine...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest